Efamol
Efamol, licence 80009719: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Efamol Evening Primrose Oil Beautiful-Skin, Efamol Evening Primrose Oil Healthy-Skin, Efamol Pure Evening Primrose Oil 1000 mg, Efamol Woman Beautiful-Skin TM Evening Primrose Oil, Efamol Woman Evening Primrose Oil Skin-so-beautiful, Efamol® Beautiful-Skin Evening Primrose Oil, Efamol® Evening Primrose Oil, Evening Primrose Oil
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 80009719
- Status
- Active licence
- Licence date
- 17 April 2009
- Revision date
- 6 October 2026
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E Source : d-alpha-tocophérol Potency : 15.0 UI | 10.0 mg EAT | Not calculated |
Non-medicinal ingredients
Glycérine, Huile de tournesol, Solution de sorbitol, simethicone, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | Not specified |
| Adultes | minimum: 12.0 Année(s) | minimum: 3.0 Capsule ; maximum: 4.0 Capsule | Not specified |
| Enfants | minimum: 1.0 Année(s) ; maximum: 11.0 Année(s) | minimum: 2.0 Capsule ; maximum: 3.0 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the treatment of dry, itchy skin caused by atopic eczema (dermatitis). A source of Vitamin E, an antioxidant for the maintenance of good health. Helps to Improve biophysical skin properties including transepidermal water loss, skin moisture, elasticity, firmness and roughness. Clinically shown to reduce transepidermal water loss. Improves skin hydration. Reduces skin roughness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80009719
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.